LEGN

Legend Biotech Corporation - American Depositary Shares (LEGN)

About Legend Biotech Corporation - American Depositary Shares (LEGN)

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Bridgewater, NJ.

Details

Daily high
$24.42
Daily low
$22.88
Price at open
$23.80
52 Week High
$37.50
52 Week Low
$16.24
Market cap
4.5B
Dividend yield
-
Volume
2.0M
Avg. volume
2.1M
P/E ratio
-46.89

Legend Biotech Corporation - American Depositary Shares News

Details

Daily high
$24.42
Daily low
$22.88
Price at open
$23.80
52 Week High
$37.50
52 Week Low
$16.24
Market cap
4.5B
Dividend yield
-
Volume
2.0M
Avg. volume
2.1M
P/E ratio
-46.89